Ni et al. [75] investigated in vitro the ABT 737 sensitivity against the high expression of Bcl-2 in liver cancer cell lines, and they demonstrated that HepG2 and Hep3B cells overexpressed Bcl-2 proteins, which were resistant to ABT 737 and apoptotic pathways. This evidence concerns the gene BCL2 and liver cancer.